Jerry Paul

Efficacy of a single dose of postoperative intravenous iron on erythropoietic recovery for Return to Intended Oncological Therapy in patients with head and neck cancer: A randomized controlled trial

Abstract Background and Aims: Perioperative anemia is a critical barrier to Return to Intended Oncological Therapy (RIOT) in head and neck cancer (HNC) patients. Surgery-induced systemic inflammation triggers a hepcidin surge, causing functional iron deficiency that limits erythr...